Blog

This Growing Pot Stock Could Make You Rich in 5 Years

The U.S. cannabis market is still trying navigate its way through what I call the "three Rs of legalization": regulations, real estate, and reality. More and more states are legalizing medical and

TheMotleyFool

0

These 2 REITs Are Safer Investments Than Their Average Customer

Like most investors, I'm a big fan of gold rushes in new or rapidly expanding industries because that's where there's the most money to be made. When it comes to picking the right stock to benefit

TheMotleyFool

0

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows

Buying a quality growth stock on a dip can be a great way to position yourself for some excellent profits. While it may be difficult to invest in something that is falling in value, if a business

TheMotleyFool

0

3 Popular Stocks Expected to Lose 53% to 79%, According to Wall Street

For more than a year, the stock market has been on a historic run. Even though all stock market crashes and corrections are eventually erased by a bull-market rally, gains of as much as 88% in the

TheMotleyFool

0

Is Vaxart a Buy?

In the early days of the pandemic, Vaxart (NASDAQ: VXRT) mesmerized investors after beginning development of a tablet-based, room-temperature-stable coronavirus vaccine. The stock subsequently

TheMotleyFool

0

Surprise! Sundial Growers Delivers Positive Adjusted EBITDA in Q1

Sundial Growers (NASDAQ: SNDL) came out of nowhere to become one of the hottest pot stocks on the market this year. However, the Canadian cannabis producer has given up much of its earlier gains

TheMotleyFool

0

2 Reasons to Invest in Cryptocurrency -- and 3 Reasons Not to

Cryptocurrency has been having quite the year. Digital currencies are the latest phenomenon in the investing world, and several different types of currencies have been shattering records.

Bitcoin

TheMotleyFool

0

Here Are the 3 Most Important Numbers in Moderna's Earnings Report

Moderna's (NASDAQ: MRNA) transformation from a clinical-stage biotech company to a commercial-stage one has been rapid -- and impressive. Only a year ago, Moderna didn't even have products on the

TheMotleyFool

0

Why Novavax Could Beat Moderna in Europe After Pfizer's Huge EU Vaccine Deal

The name of the game with COVID-19 vaccines right now is supply deals. Companies with big supply agreements are in a position to make a lot of money.

Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX)

TheMotleyFool

0

The Best Warren Buffett Stocks to Buy With $300 Right Now

Suppose one of the world's greatest investors told you some of his favorite stock picks. However, there was a problem: You only had $300 to invest, and many of his stocks were too expensive for you

TheMotleyFool

0

3 Stocks That Could Be Worth More Than Apple by 2035

The stock market is a wealth-building machine for patient investors. However, it's also dynamic.

Back in 1999, the 10 largest publicly traded companies by market cap included the likes of Lucent

TheMotleyFool

0

46% of Americans Believe This Myth That Could Needlessly Delay Social Security

Most retirees work their whole lives to become entitled to receive Social Security benefits. These retirement benefits can help cover costs in your later years once you're no longer earning a

TheMotleyFool

0

This Retirement Savings Plan Gets Even More Attractive in 2022

Healthcare is a major expense that people of all ages grapple with, but it can be an especially large burden for seniors on a fixed income. In fact, Fidelity recently reported that the average

TheMotleyFool

0